These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15850551)

  • 1. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
    Rubin RR
    Am J Med; 2005 May; 118 Suppl 5A():27S-34S. PubMed ID: 15850551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes.
    Chao J; Nau DP; Aikens JE; Taylor SD
    Res Social Adm Pharm; 2005 Dec; 1(4):508-25. PubMed ID: 17138493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient adherence to medication requirements for therapy of type 2 diabetes.
    Bailey CJ; Kodack M
    Int J Clin Pract; 2011 Mar; 65(3):314-22. PubMed ID: 21314869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
    Chao J; Nau DP; Aikens JE
    Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient's adherence in asthma.
    Gillisen A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):205-22. PubMed ID: 18204131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper.
    Breitscheidel L; Stamenitis S; Dippel FW; Schöffski O
    J Med Econ; 2010 Mar; 13(1):8-15. PubMed ID: 19947905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes.
    Bezie Y; Molina M; Hernandez N; Batista R; Niang S; Huet D
    Diabetes Metab; 2006 Dec; 32(6):611-6. PubMed ID: 17296515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived barriers and effective strategies to diabetes self-management.
    Nagelkerk J; Reick K; Meengs L
    J Adv Nurs; 2006 Apr; 54(2):151-8. PubMed ID: 16553701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
    Hauber AB; Mohamed AF; Johnson FR; Falvey H
    Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists.
    Lindenmeyer A; Hearnshaw H; Vermeire E; Van Royen P; Wens J; Biot Y
    J Clin Pharm Ther; 2006 Oct; 31(5):409-19. PubMed ID: 16958818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removing barriers to insulin use.
    Minze MG; Dalal K; Irons BK
    J Fam Pract; 2011 Oct; 60(10):577-80. PubMed ID: 21977484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneath the surface: discovering the unvoiced concerns of older adults with type 2 diabetes mellitus.
    Tjia J; Givens JL; Karlawish JH; Okoli-Umeweni A; Barg FK
    Health Educ Res; 2008 Feb; 23(1):40-52. PubMed ID: 17272292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control.
    Tan MY; Magarey J
    Patient Educ Couns; 2008 Aug; 72(2):252-67. PubMed ID: 18467068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study.
    Peyrot M; Rubin RR; Lauritzen T; Snoek FJ; Matthews DR; Skovlund SE
    Diabet Med; 2005 Oct; 22(10):1379-85. PubMed ID: 16176200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.